Tilianin inhibits the human ovarian cancer (PA-1) cell proliferation via blocking cell cycle, inducing apoptosis and inhibiting JAK2/STAT3 signaling pathway

Ovarian cancer is one of the deadliest gynecologic malignancies and is the seventh leading cause of mortalities and morbidities globally. Although there are various therapeutic strategies, a major challenge for scientific community is to come up with effective strategy to treat ovarian cancer. Tilia...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Chunqiu, Yan, Bingbing, Xia, Suhua, Yu, Fei, Zhao, Jingjing, Bai, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381034/
https://www.ncbi.nlm.nih.gov/pubmed/34466064
http://dx.doi.org/10.1016/j.sjbs.2021.06.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381034/
https://www.ncbi.nlm.nih.gov/pubmed/34466064
http://dx.doi.org/10.1016/j.sjbs.2021.06.033

Ejemplares similares